Reiki Therapy - an Intervention in Hematology/Oncology Cancer Patients Hospitalized
Launched by MAYO CLINIC · May 9, 2019
Trial Information
Current as of June 20, 2025
Withdrawn
Keywords
ClinConnect Summary
Primary Aim:
The primary aim of this study is to evaluate the feasibility of offering and providing Reiki Therapy in hospitalized hematology/oncology cancer patients. The intervention should not - interfere with the medical management of the participants. The investigators hypothesize that Reiki Sessions will be successfully integrated into conventional care of hospitalized cancer patients.
Secondary Aim:
The secondary aim is to evaluate the patient reported outcomes of their symptoms (pain, fatigue, anxiety) and feelings (happy, energetic, relaxed, and calm) before and after Reiki Thera...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hospitalized hematology-oncology patients age 18 - 80
- • Able to speak English and complete surveys
- • Able to read, understand and sign inform consent.
- Exclusion Criteria:
- • Patient unwilling for reiki therapy.
- • Unable to give written consent.
- • Already having received or receiving other reiki treatment.
- • Pregnant women. (As verbalized by participant)
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Brent Bauer, MD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials